Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Mary-Lynn Brecht & Darren Urada. (2011) Treatment Outcomes for Methamphetamine Users: California Proposition 36 and Comparison Clients. Journal of Psychoactive Drugs 43:sup1, pages 68-76.
Read now
Read now
Jessica M. Peirce, Nancy M. Petry, John M. Roll, Ken Kolodner, Joe Krasnansky, Patricia Q. Stabile, Chanda Brown & Maxine L. Stitzer. (2009) Correlates of Stimulant Treatment Outcome Across Treatment Modalities. The American Journal of Drug and Alcohol Abuse 35:1, pages 48-53.
Read now
Read now
Nena Messina, Patricia Marinelli-Casey, Maureen Hillhouse, Richard Rawson, Jeremy Hunter & Alfonso Ang. (2008) Childhood Adverse Events and Methamphetamine Use Among Men and Women. Journal of Psychoactive Drugs 40:sup5, pages 399-409.
Read now
Read now
AnnM. O'Brien, Mary-Lynn Brecht & Conerly Casey. (2008) Narratives of Methamphetamine Abuse: A Qualitative Exploration of Social, Psychological, and Emotional Experiences. Journal of Social Work Practice in the Addictions 8:3, pages 343-366.
Read now
Read now
M.
Douglas Anglin, Darren Urada, Mary-Lynn Brecht, Angela Hawken, Richard Rawson & Douglas Longshore. (2007) Criminal Justice Treatment Admissions for Methamphetamine Use in California: A Focus on Proposition 36. Journal of Psychoactive Drugs 39:sup4, pages 367-381.
Read now
Read now
Articles from other publishers (22)
Aaron E. Miller, Atul P. Daiwile & Jean Lud Cadet. (2022) Sex-Dependent Alterations in the mRNA Expression of Enzymes Involved in Dopamine Synthesis and Breakdown After Methamphetamine Self-Administration. Neurotoxicity Research 40:5, pages 1464-1478.
Crossref
Crossref
Atul P. Daiwile, Subramaniam Jayanthi & Jean Lud Cadet. (2022) Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts. Neuroscience & Biobehavioral Reviews 137, pages 104674.
Crossref
Crossref
Paxton Bach, Kanna Hayashi, M‐J Milloy, Ekaterina Nosova, Thomas Kerr, Evan Wood & Nadia Fairbairn. (2020) Characterising the increasing prevalence of crystal methamphetamine use in Vancouver, Canada, from 2006–2017: A gender‐based analysis. Drug and Alcohol Review 39:7, pages 932-940.
Crossref
Crossref
David N. Crockford, Sara Meunier & Sumantra Monty Ghosh. (2019) Methamphetamine-Induced Psychosis. The Canadian Journal of Addiction 10:4, pages 5-9.
Crossref
Crossref
Haoye Tan, Di Liang, Na Zhong, Yan Zhao, Zhikang Chen, Min Zhao & Haifeng Jiang. (2019) History of Alcohol and Opioid Use Impacts on the Long-Term Recovery Trajectories of Methamphetamine-Dependent Patients. Frontiers in Psychiatry 10.
Crossref
Crossref
Laura Hoffmann, Lisa Buchenauer, Nadine Schumann, Sara Lena Schröder, Olaf Martin & Matthias Richter. (2018) Improving Rehabilitative Care of Methamphetamine Users in Germany: The Expert’s Perspective. Qualitative Health Research 29:2, pages 248-259.
Crossref
Crossref
Anthony L. Riley, Briana J. Hempel & Matthew M. Clasen. (2018) Sex as a biological variable: Drug use and abuse. Physiology & Behavior 187, pages 79-96.
Crossref
Crossref
Adrian R. Pasareanu, John-Kåre Vederhus, Anne Opsal, Øistein Kristensen & Thomas Clausen. (2017) Mental distress following inpatient substance use treatment, modified by substance use; comparing voluntary and compulsory admissions. BMC Health Services Research 17:1.
Crossref
Crossref
Victoria Manning, David Best, Joshua B. B. Garfield, Steve Allsop, Lynda Berends & Dan I. Lubman. (2016) Money well‐spent: Further evidence of improved outcomes for methamphetamine users following treatment. Drug and Alcohol Review 36:2.
Crossref
Crossref
Maryam Moeeni, Emran M. Razaghi, Koen Ponnet, Fatemeh Torabi, Seyed Ali Shafiee & Tahereh Pashaei. (2016) Predictors of time to relapse in amphetamine-type substance users in the matrix treatment program in Iran: a Cox proportional hazard model application. BMC Psychiatry 16:1.
Crossref
Crossref
Jean Lud Cadet, Christie Brannock, Subramaniam Jayanthi & Irina N. Krasnova. (2014) Transcriptional and Epigenetic Substrates of Methamphetamine Addiction and Withdrawal: Evidence from a Long-Access Self-Administration Model in the Rat. Molecular Neurobiology 51:2, pages 696-717.
Crossref
Crossref
Mary-Lynn Brecht & Diane Herbeck. (2014) Time to relapse following treatment for methamphetamine use: A long-term perspective on patterns and predictors. Drug and Alcohol Dependence 139, pages 18-25.
Crossref
Crossref
Sharon ReifPreethy GeorgeLisa BraudeRichard H. DoughertyAllen S. DanielsSushmita Shoma GhoseMiriam E. Delphin-Rittmon. (2014) Residential Treatment for Individuals With Substance Use Disorders: Assessing the Evidence. Psychiatric Services 65:3, pages 301-312.
Crossref
Crossref
Mary-Lynn BrechtDiane M. Herbeck. (2014) Pregnancy and Fetal Loss Reported by Methamphetamine-Using Women. Substance Abuse: Research and Treatment 8, pages SART.S14125.
Crossref
Crossref
Matthew Brensilver, Keith G. Heinzerling & Steven Shoptaw. (2013) Pharmacotherapy of amphetamine‐type stimulant dependence: An update. Drug and Alcohol Review 32:5, pages 449-460.
Crossref
Crossref
Mary-Lynn Brecht, Katherine Lovinger, Diane M. Herbeck & Darren Urada. (2013) Patterns of treatment utilization and methamphetamine use during first 10years after methamphetamine initiation. Journal of Substance Abuse Treatment 44:5, pages 548-556.
Crossref
Crossref
Gantt P. Galloway, Edward G. Singleton, Raymond Buscemi, Matthew J. Baggott, René M. Dickerhoof & John E. Mendelson. (2010) An Examination of Drug Craving Over Time in Abstinent Methamphetamine Users. The American Journal on Addictions 19:6, pages 510-514.
Crossref
Crossref
Andy C. Dean, Edythe D. London, Catherine A. Sugar, Christina M.R. Kitchen, Aimee-Noelle Swanson, Keith G. Heinzerling, Ari D. Kalechstein & Steven Shoptaw. (2009) Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables. Drug and Alcohol Dependence 105:1-2, pages 48-55.
Crossref
Crossref
Melinda Campopiano. 2009. Dual Diagnosis. Dual Diagnosis
163
175
.
Ohji Kobayashi, Toshihiko Matsumoto, Masaki Otsuki, Keiko Endo, Kenichi Okudaira, Kiyoshi Wada & Yoshio Hirayasu. (2008) Profiles associated with treatment retention in Japanese patients with methamphetamine use disorder: Preliminary survey. Psychiatry and Clinical Neurosciences 62:5, pages 526-532.
Crossref
Crossref
Dean E. Dluzen & Bin Liu. (2008) Gender differences in methamphetamine use and responses: A review. Gender Medicine 5:1, pages 24-35.
Crossref
Crossref
Mary-Lynn Brecht, Lisa Greenwell & M. Douglas Anglin. (2005) Methamphetamine treatment: Trends and predictors of retention and completion in a large state treatment system (1992–2002). Journal of Substance Abuse Treatment 29:4, pages 295-306.
Crossref
Crossref